First patient dosed in Phase 1 clinical trial of new cancer drug

The Medical News · 1h ago

On August 18, 2026, in Japan, the Department of New Experimental Therapeutics and Early-Phase 1 Drug Development Service at Kansai Medical University Hospital, led by Professor Toshio SHIMIZU, administered DS1025 to the first patient worldwide as part of a global, multicenter First-in-Human Phase 1 clinical trial sponsored by Daiichi Sankyo.

Read original article on The Medical News →

First patient dosed in Phase 1 clinical trial of new cancer drug

Related news